Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Apricus, FDA agree on design for late-stage study of liver cancer drug PrevOnco; stock surges
Apricus, FDA agree on design for late-stage study of liver cancer drug PrevOnco; stock surges
Apricus, FDA agree on design for late-stage study of liver cancer drug PrevOnco; stock surges
Submitted by
admin
on November 22, 2010 - 12:35pm
Source:
Yahoo/AP
News Tags:
Apricus Biosciences
FDA
liver cancer
PrevOnco
Headline:
Apricus, FDA agree on design for late-stage study of liver cancer drug PrevOnco; stock surges
Do Not Allow Advertisers to Use My Personal information
